Skip to main content

Table 1 Comparison of infection and antibody levels between the four groups.

From: Immuno-epidemiology of human Schistosoma haematobiuminfection: preferential IgG3 antibody responsiveness to a recombinant antigen dependent on age and parasite burden

Age Groups

Infection intensity

Infection prevalence

Anti-Sh13 IgG3

Pre-peak vs. peak

t = -1.942, df = 53 p = 0.029

χ2 = 4.114, df = 1, p = 0.043

t = -1820, df = 53, p = 0037

Pre-peak vs. declining

t = -1.062, df = 102, p = 0.145

χ2 = 4.503, df = 1, p = 0.034

t = -1.441, df = 102, p = 0.077

Pre-peak vs. lowest

t = 1.709, df = 40, p = 0.048

χ2 = 0.019, df = 1, p = 0.890

t = -2.906, df = 40, p = 0.003

Peak vs. declining

t = 1.438, df = 103, p = 0.077

χ2 = 0.145, df = 1, p = 0.704

t = 0.679, df = 103, p = 0.25

Peak vs. lowest

t = 3.170, df = 41, p = 0.002

χ2 = 2.563, df = 1, p = 0.109

t = -1.165, df = 41, p = 0.126

Declining vs. lowest

t = 2.625, df = 90, p = 0.005

χ2 = 2.376, df = 1, p = 0.123

t = -2.044, df = 90, p = 0.022

  1. The table compares infection intensity, prevalence and anti-Sh13 IgG3 amongst the four groups which the population has been partitioned as shown in Figure 3. Results from post-hoc tests are presented after one way ANOVA showed that infection intensity and anti-sh13 IgG3 levels differed significantly across the 4 age groups (F = 3.863, df = 3, 147, p = 0.011 and F = 2.946, df = 3, 147, p = 0.045 for infection intensity and anti-sh13 IgG3 respectively). Significant differences are highlighted in bold font.